Skip to main content
. 2021 Jan 7;63:103165. doi: 10.1016/j.ebiom.2020.103165

Table 2.

Characteristics of HPV virus preparations.

Virus Genotype (stock ID) Source Final Virion Isolationa Physical titre (VGE/mL) Antibody neutralisation Dynamic range of infection VGE per FFUh
HPV11 (10.10) 293T QV CsCl density gradient 1.2 × 1010 99% 3-4 log10 3.8 × 104
HPV11 Xenografts b Debris Sedimentation at 11,000 x g c 2.9 × 109 98% 3 log10 5.0 × 104
HPV16 (12.35) 293T QV CsCl density gradient 3.6 × 1011 99% 4-5 log10 3.8 × 105
HPV16 (12.40) 293T QV CsCl density gradient 1.5 × 1011 100% 4-5 log10 N.D.
HPV16 HCK 16-8 Rafts Crude Virus Preparation (CVP) d,e 1.0 × 109 53% N.D.g no FFU
HPV16 (19.17) W12-E Rafts CVP 2.4 × 107 55% N.D. no FFU
HPV16 (19.40) W12-E Rafts CVP 8.4 × 106 40% N.D. no FFU
HPV31 (18.81) 293T QV CsCl density gradient 3.4 × 1010 100% 3-4 log10 1.6 × 104
HPV31 (13.02) CIN-612 9E Rafts Virion Sedimentation Ultracentrifugation f 2.0 × 108 97% ≥5 log10 3.0 × 103
a

Details of isolation in Methods.

b

Gift from N. Christensen (PennState College of Medicine).

c

VirTis homogenisation, supernatant following debris sedimentation at 11,000 x g.

d

Gift from C. Meyers (PennState College of Medicine).

e

Dounce homogenisation, low speed debris pelleting per Conway et al. 2009.

f

BeadBeater homogenisation, high-speed centrifugation, ultracentrifugation at 130,000 x g; based on sedimentation coefficient of 296S–300S for viral DNA-containing particles.

g

Not determined.

h

Based on RNA-ISH with FFU related to the total VGE exposed to cells.